{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:37:37Z","timestamp":1792719457384,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuroscience.2026.10.010","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:01:57Z","timestamp":1791561717000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Polysaccharide-based drug conjugates and related delivery systems for Alzheimer\u2019s disease: from molecular design to translational challenges"],"prefix":"10.1016","volume":"619","author":[{"given":"Ngoc Hong","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huong Thuy","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhat Thang","family":"Thi Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy Trang","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giau Van","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuroscience.2026.10.010_b0005","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/pharmaceutics14051003","article-title":"Novel luteolin-loaded chitosan decorated nanoparticles for brain-targeting delivery in a sporadic Alzheimer\u2019s disease mouse model: focus on antioxidant, anti-inflammatory, and amyloidogenic pathways","volume":"14","author":"Abbas","year":"2022","journal-title":"Pharmaceutics"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.10.010_b0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10545-013-9608-0","article-title":"Blood-brain barrier structure and function and the challenges for CNS drug delivery","volume":"36","author":"Abbott","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0015","article-title":"Brain targeting of citicoline sodium via hyaluronic acid-decorated novel nano-transbilosomes for mitigation of Alzheimer\u2019s disease in a rat model: formulation, optimization, in vitro and in vivo assessment","volume":"17(null):6347\u20136376","author":"AbouElhassan","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0020","article-title":"Oxyresveratrol-\u03b2-cyclodextrin mitigates streptozotocin-induced Alzheimer's model cognitive impairment, histone deacetylase activity in rats: in silico & in vivo studies","volume":"14(1):9897","author":"Agarwal","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.neuroscience.2026.10.010_b0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/jnc.13166","article-title":"Dextran sulfate sodium inhibits amyloid-\u03b2 oligomer binding to cellular prion protein","volume":"134","author":"Aimi","year":"2015","journal-title":"J. Neurochem."},{"issue":"12","key":"10.1016\/j.neuroscience.2026.10.010_b0030","doi-asserted-by":"crossref","first-page":"13922","DOI":"10.3390\/cimb46120832","article-title":"Assessment of modified citrus pectin\u2019s effects on dementia in the scopolamine-induced Alzheimer\u2019s model in adult male wistar rats","volume":"46","author":"Akg\u00f6l","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.010_b0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s11011-024-01484-8","article-title":"Eplingiella fruticosa leaf essential oil complexed with \u03b2-cyclodextrin exerts a neuroprotective effect in an Alzheimer\u2019s disease animal model induced by Streptozotocin","volume":"40","author":"Alexandre-Silva","year":"2024","journal-title":"Metab. Brain Dis."},{"issue":"16","key":"10.1016\/j.neuroscience.2026.10.010_b0040","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and Management of Dementia: Review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"J. Am. Med. Assoc."},{"issue":"7","key":"10.1016\/j.neuroscience.2026.10.010_b0045","doi-asserted-by":"crossref","first-page":"5629","DOI":"10.1007\/s11033-021-06512-9","article-title":"Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease","volume":"48","author":"Athar","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0050","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.carbpol.2019.05.067","article-title":"Review of polysaccharide particle-based functional drug delivery","volume":"221","author":"Barclay","year":"2019","journal-title":"Carbohydr. Polym."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.10.010_b0055","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factor reduction on Alzheimer's disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"The Lancet Neurology."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.10.010_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28020841","article-title":"Management of brain cancer and neurodegenerative disorders with polymer-based nanoparticles as a biocompatible platform","volume":"28","author":"Bazi Alahri","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.neuroscience.2026.10.010_b0065","doi-asserted-by":"crossref","DOI":"10.3390\/molecules30061297","article-title":"Chitosan and its derivatives as nanocarriers for drug delivery","volume":"30","author":"Biswas","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2026.10.010_b0070","doi-asserted-by":"crossref","unstructured":"Breijyeh, Z., Karaman, R., 2020. Comprehensive review on Alzheimer's disease: causes and treatment. Molecules. 25(24).","DOI":"10.3390\/molecules25245789"},{"issue":"3","key":"10.1016\/j.neuroscience.2026.10.010_b0075","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer's disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0080","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.4049\/jimmunol.1301695","article-title":"Spectrum and mechanisms of inflammasome activation by chitosan","volume":"192","author":"Bueter","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0090","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ijbiomac.2019.11.151","article-title":"Preparation and application of dextran and its derivatives as carriers","volume":"145","author":"Chen","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"21","key":"10.1016\/j.neuroscience.2026.10.010_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242115569","article-title":"Hyaluronic acid conjugated with 17\u03b2-estradiol effectively alleviates estropause-induced cognitive deficits in rats","volume":"24","author":"Chen","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.10.010_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.103748","article-title":"Iron oxide nanoparticles-loaded hyaluronic acid nanogels for MRI-aided Alzheimer's disease theranostics","volume":"15","author":"Chen","year":"2022","journal-title":"Arab. J. Chem."},{"issue":"10","key":"10.1016\/j.neuroscience.2026.10.010_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003426","article-title":"Disease-associated microglia in neurodegenerative diseases: friend or foe?","volume":"23","author":"Cheng","year":"2025","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0105","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.3390\/ijms20163894","article-title":"High and low molecular weight hyaluronic acid differentially influences oxylipins synthesis in course of neuroinflammation","volume":"20","author":"Chistyakov","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.neuroscience.2026.10.010_b0110","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.3390\/molecules28155893","article-title":"Curcumin\u2013sodium alginate and curcumin\u2013chitosan conjugates as drug delivery systems: an interesting rheological behaviour","volume":"28","author":"Cirillo","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.neuroscience.2026.10.010_b0115","unstructured":"ClinicalTrials.gov. A 6-month study to evaluate the safety and potential efficacy of trappsol cyclo in patients with early Alzheimer\u2019s disease. NCT05607615. https:\/\/clinicaltrials.gov\/study\/NCT05607615 (accessed September 28, 2026)."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.010_b0120","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40259-023-00633-2","article-title":"Anti-amyloid monoclonal antibodies for the treatment of Alzheimer's disease","volume":"38","author":"Cummings","year":"2024","journal-title":"BioDrugs"},{"key":"10.1016\/j.neuroscience.2026.10.010_b0125","unstructured":"Cyclo therapeutics. Phase 2b study of trappsol cyclo for the treatment of early Alzheimer\u2019s disease. https:\/\/cyclotherapeutics.com\/phase-2b-study-of-trappsol-cyclo-for-the-treatment-of-early-alzheimers-disease\/ (accessed September 28, 2026)."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.10.010_b0130","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.010_b0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"20","key":"10.1016\/j.neuroscience.2026.10.010_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232012174","article-title":"Hyaluronic acid scaffolds for loco-regional therapy in nervous system related disorders","volume":"23","author":"Djoudi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0145","doi-asserted-by":"crossref","first-page":"36928","DOI":"10.1038\/srep36928","article-title":"Endotoxin free hyaluronan and hyaluronan fragments do not stimulate TNF-\u03b1, interleukin-12 or upregulate co-stimulatory molecules in dendritic cells or macrophages","volume":"6","author":"Dong","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0150","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1007\/s10787-024-01541-9","article-title":"Preclinical efficacy of oral and nasal rivastigmine-loaded chitosan nano-particles on AlCl3-induced Alzheimer\u2019s-like disease in rats","volume":"32","author":"Elmosbah","year":"2024","journal-title":"Inflammopharmacology"},{"issue":"10","key":"10.1016\/j.neuroscience.2026.10.010_b0155","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","article-title":"Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease","volume":"33","author":"Erickson","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"22","key":"10.1016\/j.neuroscience.2026.10.010_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/polym17223055","article-title":"Recent advances on chitosan-based nanoparticles for brain drug delivery","volume":"17","author":"Ezzaki","year":"2025","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.neuroscience.2026.10.010_b0165","unstructured":"U.S. Food and Drug Administration. Withdrawn non-malignant hematological, neurological, and other disorder accelerated approvals: Aduhelm (aducanumab-avwa); withdrawal November 1, 2024. https:\/\/www.fda.gov\/drugs\/accelerated-approval-program\/withdrawn-non-malignant-hematological-neurological-and-other-disorder-indications (accessed September 28, 2026)."},{"issue":"5","key":"10.1016\/j.neuroscience.2026.10.010_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26052097","article-title":"Cellular prion protein and amyloid-\u03b2 oligomers in Alzheimer's disease-are there connections?","volume":"26","author":"Fu\u0142ek","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.010_b0175","doi-asserted-by":"crossref","first-page":"15998","DOI":"10.1038\/s41598-020-72989-2","article-title":"Hyaluronan-carnosine conjugates inhibit A\u03b2 aggregation and toxicity","volume":"10","author":"Greco","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0180","article-title":"HYDRHA: hydrogels of hyaluronic acid. New biomedical approaches in cancer, neurodegenerative diseases, and tissue engineering","volume":"17","author":"Grieco","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.10.010_b0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s42995-023-00172-3","article-title":"The neuroprotective effects of peracetylated chitosan oligosaccharides against \u03b2-amyloid-induced cognitive deficits in rats","volume":"5","author":"Hao","year":"2023","journal-title":"Mar. Life Sci. Technol."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.10.010_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/biom15060824","article-title":"The role and pathogenesis of tau protein in Alzheimer's disease","volume":"15","author":"Hong","year":"2025","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.010_b0200","doi-asserted-by":"crossref","first-page":"15844","DOI":"10.1038\/s41598-024-66897-y","article-title":"Predicting blood-brain barrier permeability of molecules with a large language model and machine learning","volume":"14","author":"Huang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0195","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jconrel.2023.12.054","article-title":"Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseases","volume":"366","author":"Huang","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.010_b0205","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1038\/s41598-018-21933-6","article-title":"Nanogels of dual inhibitor-modified hyaluronic acid function as a potent inhibitor of amyloid \u03b2-protein aggregation and cytotoxicity","volume":"8","author":"Jiang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0210","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ijbiomac.2019.04.191","article-title":"Pectin-based silver nanocomposite film for transdermal delivery of donepezil","volume":"134","author":"Kodoth","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.10.010_b0215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00415-025-13117-w","article-title":"Novel strategies for targeting tau oligomers in neurodegenerative diseases","volume":"272","author":"Lin","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0220","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1124\/dmd.109.026674","article-title":"Unbound brain concentration determines receptor occupancy: a correlation of drug concentration and brain serotonin and dopamine reuptake transporter occupancy for eighteen compounds in rats","volume":"37","author":"Liu","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0225","article-title":"Utilization of nanotechnology to surmount the blood-brain barrier in disorders of the central nervous system","volume":"31","author":"Luo","year":"2025","journal-title":"Mater. Today Bio"},{"issue":"2","key":"10.1016\/j.neuroscience.2026.10.010_b0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1039\/D3PM00075C","article-title":"Polymer\u2013drug conjugates as nano-sized multi-targeting systems for the treatment of Alzheimer's disease [10.1039\/D3PM00075C]","volume":"1","author":"Mahadik","year":"2024","journal-title":"RSC Pharmaceutics."},{"issue":"21","key":"10.1016\/j.neuroscience.2026.10.010_b0235","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1021\/acschemneuro.4c00392","article-title":"Mannose-functionalized chitosan-coated PLGA nanoparticles for brain-targeted codelivery of CBD and BDNF for the treatment of Alzheimer's disease","volume":"15","author":"Mahanta","year":"2024","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2019.11.009","article-title":"The blood-brain barrier: physiology and strategies for drug delivery","volume":"165\u2013166","author":"Pandit","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"22","key":"10.1016\/j.neuroscience.2026.10.010_b0245","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212309","article-title":"The effect of oxidative stress and memantine-incorporated reactive oxygen species-sensitive nanoparticles on the expression of N-methyl-d-aspartate receptor subunit 1 in brain cancer cells for Alzheimer's disease application","volume":"22","author":"Park","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.10.010_b0250","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16049","article-title":"Anti-amyloid antibody treatments for Alzheimer's disease","volume":"31","author":"Perneczky","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0255","article-title":"Recent update on the chemical modalities of mucoadhesive biopolymeric systems for safe and effective drug delivery","volume":"44","author":"Puri","year":"2025","journal-title":"Appl. Mater. Today"},{"key":"10.1016\/j.neuroscience.2026.10.010_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2024.100755","article-title":"A molecular dynamics investigation into the inhibitory function of hydroxypropyl-beta-cyclodextrin (HPBCD) in its interaction with amyloid-beta (A\u03b2) plaques near the cell membrane in the context of Alzheimer's disease","volume":"9","author":"Rezaeisadat","year":"2024","journal-title":"Chem. Phys. Impact"},{"key":"10.1016\/j.neuroscience.2026.10.010_b0265","article-title":"Nose-to-brain targeted delivery of donepezil hydrochloride via novel hyaluronic acid-doped nanotransfersomes for Alzheimer's disease mitigation","volume":"113","author":"Salem","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0270","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0275","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.5c00956","article-title":"Targeting hyaluronic acid increases brain retention of intraventricular dosed antibodies in mice","author":"Schwinghamer","year":"2026","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0280","doi-asserted-by":"crossref","DOI":"10.1002\/alz70859_104294","article-title":"TRONTIER 1 and TRONTIER 2: pivotal trials of trontinemab in early symptomatic Alzheimer\u2019s disease","volume":"21","author":"Smith","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0285","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1074\/jbc.M113.515106","article-title":"Low molecular weight hyaluronan activates cytosolic phospholipase A2\u03b1 and eicosanoid production in monocytes and macrophages","volume":"289","author":"Soko\u0142owska","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0290","doi-asserted-by":"crossref","first-page":"12358","DOI":"10.1038\/s41598-020-69096-7","article-title":"Transcriptomic comparison of human and mouse brain microvessels","volume":"10","author":"Song","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0295","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.biomaterials.2018.12.027","article-title":"Progressive release of mesoporous nano-selenium delivery system for the multi-channel synergistic treatment of Alzheimer's disease","volume":"197","author":"Sun","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.neuroscience.2026.10.010_b0300","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1038\/s41467-021-23997-x","article-title":"Unravelling cytosolic delivery of cell penetrating peptides with a quantitative endosomal escape assay","volume":"12","author":"Teo","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0305","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.carbpol.2016.03.014","article-title":"Synthesis and evaluation of oxidation-responsive alginate-deferoxamine conjugates with increased stability and low toxicity","volume":"144","author":"Tian","year":"2016","journal-title":"Carbohydr. Polym."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.10.010_b0310","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ibra.12199","article-title":"Immunomodulatory natural polysaccharide-based nanoparticles for the treatment of neurodegenerative diseases","volume":"11","author":"Tziveleka","year":"2025","journal-title":"Ibrain"},{"issue":"1","key":"10.1016\/j.neuroscience.2026.10.010_b0315","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","article-title":"The blood\u2013brain barrier: structure, regulation and drug delivery","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.10.010_b0320","doi-asserted-by":"crossref","first-page":"255","DOI":"10.37349\/en.2024.00048","article-title":"Current therapeutics for Alzheimer \u2019 s disease and clinical trials","volume":"3","author":"Xiao","year":"2024","journal-title":"Explor. Neurosci."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.10.010_b0325","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/01480545.2024.2349951","article-title":"Potential neuroprotective effects of 2-hydroxypropyl-\u03b2 cyclodextrin against amyloid \u03b2 (1-42)-induced neurotoxicity on the rat hippocampus","volume":"47","author":"Yalcin","year":"2024","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0330","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2217\/nnm-2019-0169","article-title":"Nanoparticle brain delivery: a guide to verification methods","volume":"15","author":"Yokel","year":"2020","journal-title":"Nanomedicine (Lond.)"},{"key":"10.1016\/j.neuroscience.2026.10.010_b0335","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002230","article-title":"Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target","volume":"3","author":"Yu","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"2","key":"10.1016\/j.neuroscience.2026.10.010_b0340","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/1061186X.2020.1817041","article-title":"Development, optimisation and evaluation of chitosan nanoparticles of alendronate against Alzheimer\u2019s disease in intracerebroventricular streptozotocin model for brain delivery","volume":"29","author":"Zameer","year":"2021","journal-title":"J. Drug Target."},{"issue":"6","key":"10.1016\/j.neuroscience.2026.10.010_b0345","doi-asserted-by":"crossref","first-page":"7605","DOI":"10.1007\/s00210-024-03696-2","article-title":"Protective effects of polydatin amphiphilic chitosan nanocarriers against an aluminum chloride-induced model of Alzheimer\u2019s disease in rats: relevance to its anti-inflammatory and antioxidant effects","volume":"398","author":"Zarneshan","year":"2025","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0350","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ijbiomac.2022.01.154","article-title":"Ultra-stable dextran conjugated prodrug micelles for oxidative stress and glycometabolic abnormality combination treatment of Alzheimer's disease","volume":"203","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0375","article-title":"Macromolecular nanoparticles to attenuate both reactive oxygen species and inflammatory damage for treating Alzheimer's disease","volume":"8","author":"Zhang","year":"2022","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2026.111887","article-title":"The dual role of microglia in neurodegenerative diseases: a review","volume":"239","author":"Zhang","year":"2026","journal-title":"Brain Res. Bull."},{"issue":"48","key":"10.1016\/j.neuroscience.2026.10.010_b0365","doi-asserted-by":"crossref","first-page":"33032","DOI":"10.1021\/acsnano.4c05693","article-title":"Multi targeted therapy for Alzheimer's disease by guanidinium-modified calixarene and cyclodextrin co-assembly loaded with insulin","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.neuroscience.2026.10.010_b0360","article-title":"Transnasal-brain delivery of nanomedicines for neurodegenerative diseases [review]","volume":"3\u20132023","author":"Zhang","year":"2023","journal-title":"Front. Drug Delivery"},{"key":"10.1016\/j.neuroscience.2026.10.010_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.119961","article-title":"Advances in polysaccharides of natural source of the anti-Alzheimer's disease effect and mechanism","volume":"296","author":"Zhang","year":"2022","journal-title":"Carbohydr. Polym."},{"issue":"3","key":"10.1016\/j.neuroscience.2026.10.010_b0380","doi-asserted-by":"crossref","DOI":"10.1063\/5.0013178","article-title":"Microglia-targeting nanotherapeutics for neurodegenerative diseases","volume":"4","author":"Zhao","year":"2020","journal-title":"APL Bioeng."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0385","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.carbpol.2018.08.050","article-title":"A pectin from fruits of Lycium barbarum L. decreases \u03b2-amyloid peptide production through modulating APP processing","volume":"201","author":"Zhou","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"9","key":"10.1016\/j.neuroscience.2026.10.010_b0390","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.3390\/md13095828","article-title":"Alginate-derived oligosaccharide inhibits neuroinflammation and promotes microglial phagocytosis of \u03b2-amyloid","volume":"13","author":"Zhou","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.neuroscience.2026.10.010_b0395","article-title":"Polymers for the treatment of Alzheimer's disease","volume":"16","author":"Zhu","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"Pt 1","key":"10.1016\/j.neuroscience.2026.10.010_b0405","article-title":"Intranasal administration of dextran-pramlintide polyelectrolyte complex-coated nanoemulsions improves cognitive impairments in a mouse model of Alzheimer's disease","volume":"281","author":"Zuglianello","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuroscience.2026.10.010_b0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.104527","article-title":"Polysaccharide-peptide complexes stabilized around nanoemulsion droplets: a new approach for nasal delivering of pramlintide and insulin","volume":"85","author":"Zuglianello","year":"2023","journal-title":"J. Drug Delivery Sci. Technol."}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222600672X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645222600672X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:42:44Z","timestamp":1792716164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645222600672X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":81,"alternative-id":["S030645222600672X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.10.010","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polysaccharide-based drug conjugates and related delivery systems for Alzheimer\u2019s disease: from molecular design to translational challenges","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2026.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Brain Research Organization (IBRO). Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}